CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease

Parkinson’s disease (PD) and other chronic and debilitating neurodegenerative diseases (NDs) impose a substantial medical, emotional, and financial burden on individuals and society. The origin of PD is unknown due to a complex combination of hereditary and environmental risk factors. However, over...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Mujeeb ur, Bilal, Muhammad, Shah, Junaid Ali, Kaushik, Ajeet, Teissedre, Pierre-Louis, Kujawska, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229276/
https://www.ncbi.nlm.nih.gov/pubmed/35745824
http://dx.doi.org/10.3390/pharmaceutics14061252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229276/
https://www.ncbi.nlm.nih.gov/pubmed/35745824
http://dx.doi.org/10.3390/pharmaceutics14061252

Ejemplares similares